Dr Feifel and Dr Dan Press (Harvard Neurology) presents on latest TMS developments
Kadima's patient Barbara, is featured in Time's cover story on ketamine.
Our proprietary "My Journey" helps patient's identify improvement they are experiencing in multiple domains and improve decision making by Kadima providers.
Dr. Feifel presenting at the first international conference on ketamine for depression at Oxford University, UK
Dr. Feifel giving an invited lecture on Adult ADHD at the Learning Development Center in San Diego
Ketamine Pioneers: L to R: Dennis Charney, MD the first to discover ketamine's antidepressant effect, David Feifel, MD, PhD, established the first ketamine infusion program for psychiatric disorders, Ed Domino, MD was the first to test ketamine in humans in 1962
Team members from Compass Pathways and Kadima during research initiation meeting at Kadima. Compass Pathways is working on developing psilocybin as an FDA approved medication for depression and other conditions .
Kopper taking a snack break. Putting patients at ease all day builds an appetite.
Dr. Kopper and her associate, Dr. Feifel
Kopper our office therapy dog, loves her job!
Patients love our serene courtyard.
Dr. Feifel with Brainsway's technology development team
Dr. Feifel indulging his inner mad scientist :)
